Reviva Pharmaceuticals Holdings Inc. (RVPH) — Strategic Asset Allocation Index
Reviva Pharmaceuticals Holdings Inc. (RVPH) has a Strategic Asset Allocation Index of 0.0% as of September 2020. Strategic assets (PP&E of $107.00 plus long-term investments of $-) total $107.00, measured against net assets of $30.10 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Reviva Pharmaceuticals Holdings Inc. Strategic Asset Allocation Index (2018–2018)
This chart shows how Reviva Pharmaceuticals Holdings Inc.'s Strategic Asset Allocation Index has evolved across 1 annual periods from 2018 to 2018. As of September 2020, the index stands at 0.0%, representing strategic assets of $107.00 against net assets of $30.10 Million USD. Explore Reviva Pharmaceuticals Holdings Inc. (RVPH) cash conversion ratio to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Reviva Pharmaceuticals Holdings Inc. (2018–2018)
The table below presents the year-by-year Strategic Asset Allocation Index for Reviva Pharmaceuticals Holdings Inc. from 2018 to 2018, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Reviva Pharmaceuticals Holdings Inc. stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2018 | 0.0% | $1.24K | $1.24K | $- | $59.16 Million | — |